226 related articles for article (PubMed ID: 16112003)
1. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor.
Motoi T; Ishida T; Kawato A; Motoi N; Fukayama M
Hum Pathol; 2005 Aug; 36(8):871-7. PubMed ID: 16112003
[TBL] [Abstract][Full Text] [Related]
2. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
3. Isolation and developmental expression of Mitf in Xenopus laevis.
Kumasaka M; Sato H; Sato S; Yajima I; Yamamoto H
Dev Dyn; 2004 May; 230(1):107-13. PubMed ID: 15108314
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
Kim DS; Park SH; Park KC
Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
7. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
[TBL] [Abstract][Full Text] [Related]
9. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):493-501. PubMed ID: 18223480
[TBL] [Abstract][Full Text] [Related]
11. Fifteen-year quest for microphthalmia-associated transcription factor target genes.
Cheli Y; Ohanna M; Ballotti R; Bertolotto C
Pigment Cell Melanoma Res; 2010 Feb; 23(1):27-40. PubMed ID: 19995375
[TBL] [Abstract][Full Text] [Related]
12. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
Lekmine F; Salti GI
J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
[TBL] [Abstract][Full Text] [Related]
13. Dichloromethane fraction of Cimicifuga heracleifolia decreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells.
Jang JY; Lee JH; Kang BW; Chung KT; Choi YH; Choi BT
Exp Dermatol; 2009 Mar; 18(3):232-7. PubMed ID: 18803655
[TBL] [Abstract][Full Text] [Related]
14. Case of pigmented neurofibroma with hypertrichosis with no association to neurofibromatosis.
Na CH; Song IG; Chung BS; Shin BS
J Dermatol; 2009 Oct; 36(10):541-4. PubMed ID: 19785708
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
16. 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation.
Jiang Z; Xu J; Long M; Tu Z; Yang G; He G
Life Sci; 2009 Aug; 85(9-10):345-50. PubMed ID: 19527735
[TBL] [Abstract][Full Text] [Related]
17. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
McCarron KF; Goldblum JR
Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
[TBL] [Abstract][Full Text] [Related]
18. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Mod Pathol; 2001 Jan; 14(1):6-9. PubMed ID: 11211309
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
20. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]